Drug Trial Radar · NCT05248867
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
Last checked: Nov 20, 2026Latest source record: May 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
638
Actual
Start
Mar 16, 2022
Primary completion
Mar 17, 2023
Study completion Mar 17, 2023
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Feb 21, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Facial lines that develop from repeated facial expression, such as glabellar lines (GL), are typically treated by selectively weakening specific muscles with small quantities of botulinum toxin. AGN-151586 is an investigational product being developed for the treatment of GL. The purpose of this study was to evaluate the safety and efficacy of AGN-151586 for the treatment of GL in participants with moderate to severe GL. This was a 12-week study in which eligible subjects were enrolled into the study containing 2 treatment periods, double-blind period and open-label period. Participants were randomly assigned to receive AGN-151586 or placebo. There was 1 in a 4 chance that participants would receive placebo. Around 600 adult participants with moderate to severe GL were to be enrolled in the study in approximately 38 sites across the world. Participants received either AGN-151586 or Placebo administered as 5 intramuscular injections to the glabellar complex on Day 1. Participants meeting retreatment criteria may have received an open-label treatment of AGN-151586 during the study. Participants attended regular visits during the study at a study site. The effect of the treatment was checked by medical assessments, blood tests, telephone calls, questionnaires and checking for side effects.
Conditions
- Glabellar Lines
Interventions
PlaceboDrug
Placebo solution for injection
AGN-151586Drug
AGN-151586 solution for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With a Grade 0 or 1 and a ≥ 2-grade Improvement From Baseline on the FWS According to Both Investigator and Subject Assessments of Glabellar Lines (GL) Severity at Maximum Frown at Day 7 [US FDA]Time frame: Baseline, Day 7 (Double-blind period)
- Percentage of Participants With a ≥ 2-grade Improvement From Baseline on the FWS According to Participant Assessment of Glabellar Lines (GL) Severity at Maximum Frown at Day 7 [European Union Regulatory Agencies]Time frame: Baseline, Day 7 (Double-blind period)
- Percentage of Participants With a ≥ 2-grade Improvement From Baseline on the FWS According to Investigator Assessment of Glabellar Lines (GL) Severity at Maximum Frown at Day 7 [European Union Regulatory Agencies]Time frame: Baseline, Day 7 (Double-blind Period)
- Number of Participants With Adverse EventsTime frame: From time of informed consent to end of study; median time on follow-up was 85 days for Double-blind Placebo, AGN-151586, Open-label Placebo/AGN-151586 and AGN-151586/AGN-151586 groups, 50 days for Placebo/None group, and 53 days for AGN-151586/None group
Locations
38 sites in 5 countries. Site status is shown where the registry gives one.
Total Skin and Beauty Derm Ctr /ID# 232378
Birmingham, Alabama
Clinical Testing of Beverly Hills /ID# 233195
Encino, California
Westside Aesthetics /ID# 232443
Los Angeles, California
The Research Center at The Maas Clinic /ID# 241262
San Francisco, California
Center for Dermatology and Dermatologic Surgery /ID# 232315
Washington D.C., District of Columbia
Steven Fagien MD Aesthetic Eyelid Plastic Surgery /ID# 232439
Boca Raton, Florida
Dermatology Clinic & Cosmetic Center /ID# 244295
Baton Rouge, Louisiana
Delricht Research /ID# 241253
New Orleans, Louisiana
Skincare Physicians /ID# 233938
Chestnut Hill, Massachusetts
BOYD Beauty Birmingham /ID# 232383
Birmingham, Michigan
Skin Search of Rochester Inc. /ID# 232549
Rochester, New York
Aesthetic Solutions /ID# 232389
Chapel Hill, North Carolina
Aventiv Research Dublin /ID# 233936
Dublin, Ohio
KGL Skin Study Center, LLC /ID# 233549
Newtown Square, Pennsylvania
Nashville Center for Laser and Facial Surgery /ID# 242535
Nashville, Tennessee
Westlake Dermatology & Cosmetic Surgery - Westlake /ID# 232410
Austin, Texas
Dallas Plastic Surgery Institute /ID# 232328
Dallas, Texas
Austin Institute for Clinical Research at SBA Dermatology /ID# 232316
Houston, Texas
Beacon Dermatology Inc /ID# 233227
Calgary, Alberta, Canada
Alberta DermaSurgery Centre /ID# 241172
Edmonton, Alberta, Canada
Dr. Wei Jing Loo Medicine Prof /ID# 241863
London, Ontario, Canada
Erevna Innovations Inc. /ID# 239592
Westmount, Quebec, Canada
Noahklinik GmbH /ID# 241184
Kassel, Germany
Hautok and Hautok-cosmetics /ID# 232393
München, Germany
Privatpraxis fuer Dermatologie und Aesthetik /ID# 241544
München, Germany
MediCorium Zentrum fuer Dermatologie und Aesthetik /ID# 241186
Oberursel, Germany
Studienzentrum Theatiner46 /ID# 241185
Munich, Bavaria, Germany
Rosenpark Research /ID# 232391
Darmstadt, Hesse, Germany
Privatpraxis Dr. Hilton & Partner /ID# 232392
Düsseldorf, North Rhine-Westphalia, Germany
Derma-B Egeszsegugyi es Szolgaltato Kft. /ID# 244706
Debrecen, Hungary
Pecsi Tudomanyegyetem Klinikai Kozpont /ID# 244707
Pécs, Hungary
Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont /ID# 244708
Szeged, Csongrád megye, Hungary
Derm-Surg Kft. /ID# 244709
Kaposvár, Somogy County, Hungary
Instytut Zdrowia Dr Boczarska-Jedynak Sp. Z O.O. Sp.K. /Id# 242990
Oświęcim, Lesser Poland Voivodeship, Poland
Dermed Centrum Medyczne Sp. z o.o /ID# 242972
Lodz, Łódź Voivodeship, Poland
Clinical Research Group Sp. z o.o. /ID# 242988
Warsaw, Masovian Voivodeship, Poland
High-Med Przychodnia Specjalistyczna /ID# 242973
Warsaw, Masovian Voivodeship, Poland
Novo-Med Zielinski i Wspolnicy Spolka Jawna /ID# 242986
Katowice, Silesian Voivodeship, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.